| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Revenue | $839.0M | +4.1% |
| Cost of Revenue | $567.8M | +2.6% |
| Gross Profit | $271.2M | +7.5% |
| R&D Expense | $19.1M | -5.0% |
| SG&A Expense | $147.6M | +6.2% |
| Operating Income | $66.0M | -19.3% |
| Pre-tax Income | $62.4M | +23.6% |
| Income Tax | $14.0M | +21.7% |
| Net Income | $48.4M |
| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.0M | +65.5% |
| Accounts Receivable | $116.0M | +10.9% |
| Inventory | $188.6M | -0.8% |
| Current Assets | $414.9M | +8.0% |
| Total Assets | $1.51B | +0.6% |
| Current Liabilities | $143.2M | +3.3% |
| Long-term Debt | $368.0M | -18.3% |
| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $127.3M | +4.3% |
| Capital Expenditures | $23.7M | -12.2% |
| Investing Cash Flow | $20.3M | +167.0% |
| Financing Cash Flow | -$121.9M | -55.5% |
| Free Cash Flow | $103.6M | +8.9% |
| +24.1% |
| EPS (Basic) | $1.46 | +24.8% |
| EPS (Diluted) | $1.45 | +23.9% |
| Total Liabilities |
| $583.0M |
| -9.0% |
| Stockholders' Equity | $931.5M | +7.8% |